74635-2024 - Frivillig förhandsinsyn
Sverige – Små djur – In vivo models
OJ S 25/2024 05/02/2024
Meddelande om frivillig förhandsinsyn
Varor
1. Upphandlare
1.1.
Upphandlare
Officiellt namnKarolinska Institutet
E-postadresshanna.glad@ki.se
2. Förfarande
2.1.
Förfarande
TitelIn vivo models
BeskrivningKI needs to purchase two genetic in vivo models (mouse strains) to cancer research. Crucial mandatory requirements: 1) The company must use radioactive Southern Blotting with 5 ', 3 ', and internal probes, on multiple genomic DNA restriction digests for genetic quality controls. This is the gold standard for quality control in genetic modifications and ensures that during the recombination the neighboring DNA is left unaffected. 2) Animal welfare must conform to approved legislation (Direktive 201 0 _ 63 _ EU and local), health monitoring must be according to FELASA recommendations, the animals produced must match the health standard allowing import into animal facility at Karolinska Institutet (C-Barrier), transport of the produced animals to the Karolinska Institutet must be done by ground transport in approved transport crates. 3) Maintaining the genetic background of the new strains when crossing to our already established lines. Taconic Biosciences Inc (Taconic) is, to KI’s knowledge, the only company that uses 3 probes for the southern blot as validation for ES cell targeting. Taconic is the only company fulfilling the health requirements of the KI animal facility allowing direct import of live mice into the animal house. Also, to maintain the genetic background in crosses between the strains that will be generated in the course of this project and the strains we established earlier, Taconic is the company of choice because the previous strains were established using ES cells from Taconic. Taconic derived these from C57BL6/NTac strain and these are not available to any other company. Using the same ES cells ensures that in future crosses with the new strain and the old strain any change in phenotype can be more reliably attributed to the introduced gene mutation rather than due to changes in the genetic background. KI will sign a contract with Taconic after a standstill period of 10 days after publishing this Voluntary ex ante transparency notice.
Förfarandets identifierare431ad048-ff05-4f05-8ff8-843c4ad9af81
Intern identifierare2-471/2024
Typ av förfarandeFörhandlat förfarande utan föregående meddelande om upphandling
2.1.1.
Föremålet för upphandlingen
Kontraktets artVaror
Huvudklassificering (cpv): 03325000 Små djur
2.1.2.
Leveransplats
OrtSolna
2.1.4.
Allmänna upplysningar
Rättslig grund
Direktiv 2014/24/EU
5. Del (anbudsområde)
5.1.
Del (anbudsområde)LOT-0000
TitelIn vivo models
BeskrivningKI needs to purchase two genetic in vivo models (mouse strains) to cancer research. Crucial mandatory requirements: 1) The company must use radioactive Southern Blotting with 5 ', 3 ', and internal probes, on multiple genomic DNA restriction digests for genetic quality controls. This is the gold standard for quality control in genetic modifications and ensures that during the recombination the neighboring DNA is left unaffected. 2) Animal welfare must conform to approved legislation (Direktive 201 0 _ 63 _ EU and local), health monitoring must be according to FELASA recommendations, the animals produced must match the health standard allowing import into animal facility at Karolinska Institutet (C-Barrier), transport of the produced animals to the Karolinska Institutet must be done by ground transport in approved transport crates. 3) Maintaining the genetic background of the new strains when crossing to our already established lines. Taconic Biosciences Inc (Taconic) is, to KI’s knowledge, the only company that uses 3 probes for the southern blot as validation for ES cell targeting. Taconic is the only company fulfilling the health requirements of the KI animal facility allowing direct import of live mice into the animal house. Also, to maintain the genetic background in crosses between the strains that will be generated in the course of this project and the strains we established earlier, Taconic is the company of choice because the previous strains were established using ES cells from Taconic. Taconic derived these from C57BL6/NTac strain and these are not available to any other company. Using the same ES cells ensures that in future crosses with the new strain and the old strain any change in phenotype can be more reliably attributed to the introduced gene mutation rather than due to changes in the genetic background. KI will sign a contract with Taconic after a standstill period of 10 days after publishing this Voluntary ex ante transparency notice.
Intern identifierare2-471/2024
5.1.1.
Föremålet för upphandlingen
Kontraktets artVaror
Huvudklassificering (cpv): 03325000 Små djur
Mängd2
5.1.2.
Leveransplats
OrtSolna
5.1.6.
Allmänna upplysningar
Upphandlingsprojekt som inte finansieras med EU-medel
Upphandlingen omfattas av Världshandelsorganisationens avtal om offentlig upphandling, GPAnej
5.1.16.
Kompletterande information, medling och prövning
PrövningsorganisationFörvaltningsrätten
TED eSenderMercell Holding ASA
6. Resultat
Värdet av alla de kontrakt som tilldelas i det här förfarandet83 600,00 EUR
Direkttilldelning
Motivering av direkttilldelningKontraktet kan endast tillhandahållas av en viss leverantör på grund av bristande konkurrens av tekniska skäl
6.1.
Resultat – delkontraktets idLOT-0000
6.1.2.
Information om vinnarna
Verklig ägare
Officiellt namnTaconic Biosciences, Inc.
Anbud
Identifierare för anbudsgivare2-471/2024
Identifierare för del eller grupp av delarLOT-0000
Värde på upphandlingen83 600,00 EUR
Information om kontraktet
Identifierare för kontraktet2-471/2024
TitelIn vivo models
Datum då vinnaren utsågs30/01/2024
8. Organisationer
8.1.
ORG-0001
Officiellt namnKarolinska Institutet
Registreringsnummer2021002973
AvdelningUpphandlare
PostadressNobels väg 5
OrtSTOCKHOLM
Postnummer17177
LandSverige
KontaktpunktHanna Glad
E-postadresshanna.glad@ki.se
Tfn+46 08-52480000
Webbadresshttp://www.ki.se
Den här organisationens roller
Upphandlare
8.1.
ORG-0002
Officiellt namnFörvaltningsrätten
Registreringsnummer202100-2742
OrtStockholm
Postnummer115 76
Del av land (NUTS)Stockholms län (SE110)
LandSverige
E-postadressforvaltningsrattenistockholm@dom.se
Tfn08-561 680 00
Webbadresshttps://www.domstol.se/forvaltningsratten-i-stockholm/
Den här organisationens roller
Prövningsorganisation
8.1.
ORG-0003
Officiellt namnTaconic Biosciences, Inc.
Organisationen är en fysisk person
OrtGermantown
LandFörenta staterna
E-postadressinfo@taconic.com
Tfn+4570230405
Den här organisationens roller
Anbudsgivare
Vinnare av de här delkontraktenLOT-0000
8.1.
ORG-0004
Officiellt namnMercell Holding ASA
Registreringsnummer980921565
PostadressAskekroken 11
OrtOslo
Postnummer0277
Del av land (NUTS)Oslo (NO081)
LandNorge
KontaktpunkteSender
E-postadresspublication@mercell.com
Tfn+47 21018800
Fax+47 21018801
Webbadresshttp://mercell.com/
Den här organisationens roller
TED eSender
Information om meddelandet
Identifierare/version för meddelandet7156e38a-0894-4b50-a755-d338debbf980  -  01
FormulärtypFrivillig förhandsinsyn
MeddelandetypMeddelande om frivillig förhandsinsyn
Meddelandets undertyp25
Avsändningsdatum för meddelandet01/02/2024 15:38:30 (UTC+00:00) Västeuropeisk tid
Datum för avsändning av meddelandet (eSender)01/02/2024 15:40:10 (UTC+00:00) Västeuropeisk tid
Språk som det här meddelandet finns officiellt tillgängligt påengelska
Meddelandets publiceringsnummer74635-2024
EUT S-nummer25/2024
Publiceringsdatum05/02/2024